Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
BMC Cancer|August 22, 2020
Height as a risk factor in meningioma: a study of 2 million Israeli adolescentsMatan Ben-Zion Berliner, Lior Haim Katz, Estela Derazne, et al.Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.Neuro-Oncology|April 22, 2010
Gliomas display a microRNA expression profile reminiscent of neural precursor cellsIris Lavon, Daniel Zrihan, Avital Granit, et al.Molecular Oncology|December 7, 2021
Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysisVikrant Palande, Tali Siegal, Rajesh Detroja, et al.Cancer|August 12, 2023
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphomaOsnat Bairey, Alisa Taliansky, Amir Glik, et al.Haematologica|July 29, 2021
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaOhad Benjamini, Lior Rokach, Gilad Itchaki, et al.Neuro-Oncology|February 25, 2021
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjectsRoi Tschernichovsky, Lior H Katz, Estela Derazne, et al.Cancer Medicine|December 29, 2023
Is serum-derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory studyOrit Uziel, Andrew A Kanner, Einat Beery, et al.Leukemia & Lymphoma|June 23, 2025
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapyJohn Kuruvilla, Dipenkumar Modi, Armando Santoro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experienceLilyana Angelov, Nancy D Doolittle, Dale F Kraemer, et al.Pageof 15